Pure Global

Impact of Oral Protein on Nutritional Status and Quality of Life in HD Patients - Trial NCT05952570

Access comprehensive clinical trial information for NCT05952570 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05952570
Not yet recruiting
dietary supplement
Trial Details
ClinicalTrials.gov • NCT05952570
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Impact of Oral Protein on Nutritional Status and Quality of Life in HD Patients
The Impact of Oral Protein-based Supplements on Nutritional Status and Quality of Life in Hemodialysis Patients

Study Focus

Hemodialysis Complication

oral protein nutritional supplement (Fresubin protein powder)

Interventional

dietary supplement

Sponsor & Location

Alexandria University

Alexandria, Egypt

Timeline & Enrollment

N/A

Aug 01, 2023

Dec 15, 2023

100 participants

Primary Outcome

effect on nutritional status,effect on quality of life

Summary

The aim of this work is to study the effects of oral protein-based supplements on nutritional
 status in hemodialysis patients

ICD-10 Classifications

Kidney dialysis
Other dialysis
Care involving dialysis
Mechanical complication of vascular dialysis catheter
Haemoglobinuria due to haemolysis from other external causes

Data Source

ClinicalTrials.gov

NCT05952570

Non-Device Trial